CSOP Hang Seng Biotech ETF (03174.HK) Rises 2.54% in Early Trading, NAV Per Unit at HK$3.304

NewTimeSpace News: As at 09:42 on August 4, 2026, CSOP Hang Seng Biotech ETF (03174.HK) rose 2.54% to HK$3.394. The ETF traded 407,800 shares with a turnover value of HK$1.3883 million, an average price of HK$3.404, volume ratio of 7.44, turnover rate of 0.16% and amplitude of 1.09%. Its current net asset value per unit stands at HK$3.304, assets under management of HK$839 million, with each board lot consisting of 100 shares.

CSOP Hang Seng Biotech ETF (03174.HK) tracks the Hang Seng Biotech Index. The index focuses on leading biotech companies listed in Hong Kong, covering sectors including innovative drugs, CXO, vaccines and gene therapy.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.